Testing

Genetic testing is like security-camera video footage of a break-in, providing essential clues to identify a culprit. In certain cancers, the “culprit” might be a rearrangement in a person’s DNA, which genomic testing can capture. Mayo Clinic has developed a novel group of clinical tests that zoom in on a person’s genome to characterize chromosomal rearrangements.

By Barbara J. Toman • August 20, 2018

The following list of updates were posted to MayoMedicalLaboratories.com during the month of July 2018: […]

By Erika Fetterman • August 14, 2018

In July 2018, Mayo Medical Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • August 9, 2018

The following list of updates were posted to MayoMedicalLaboratories.com during the month of June 2018: […]

By Erika Fetterman • July 12, 2018

In June 2018, Mayo Medical Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • July 12, 2018

High-sensitivity troponin T is a new assay recently approved by the U.S. Food and Drug Administration. This assay is most often used to evaluate patients with possible acute ischemic heart disease, but it also has a variety of uses in the more chronic setting.

By Mayo Medical Laboratories • June 25, 2018

The following list of updates were posted to MayoMedicalLaboratories.com during the month of May 2018: […]

By Erika Fetterman • June 15, 2018

There are many probable causes of chronic diarrhea and abdominal pain, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, infectious GI pathogens, and malignancy. After excluding other causes of chronic diarrhea, a physician is left with the diagnosis IBS-diarrhea (IBS-D). One main cause of IBS-D is bile acid malabsorption.

By Alyssa Frank • June 1, 2018

Mayo Clinic’s unique combination of specialized laboratories and gastroenterology patient care clinics gives us the ability to put into practice clinically proven, cost-effective, patient care-driven testing approaches for hundreds of GI conditions. Visit Mayo Medical Laboratories at booth #2508 at DDW 2018 to discuss how our testing can integrate with your practice and extend your network to include some of the world’s leading GI experts.

By Mayo Medical Laboratories • June 1, 2018

The following list of updates were posted to MayoMedicalLaboratories.com during the month of April 2018.

By Erika Fetterman • May 29, 2018

In April 2018, Mayo Medical Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • May 24, 2018

Hereditary neuromuscular disorders are quite varied in their presentations and even more diverse in terms of their specific genetic causes. Sometimes, these disorders can be framed in terms of the extent of weakness, sensory involvement, and/or autonomic involvements, but in other instances, it may be difficult to discern the appropriate test for many patients based on phenotype.

By Mayo Medical Laboratories • April 24, 2018

At Mayo Clinic, we know the importance of laboratory testing in a patient’s episode of care. Our unique combination of specialized laboratories and neurology patient care clinics gives us the ability to put into practice clinically proven, cost-effective, patient care-driven testing approaches for hundreds of neurological conditions.

By Mayo Medical Laboratories • April 21, 2018